{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:10:17Z","timestamp":1789560617696,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetic Engineering and Biotechnology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jgeb.2026.100788","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:24:28Z","timestamp":1786019068000},"page":"100788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of serum MicroRNAs and HCV Core antigen as predictive and diagnostic biomarkers for chronic hepatitis C management in Iraqi patients: comparison with PCR-based detection"],"prefix":"10.1016","volume":"24","author":[{"given":"Basheer Saleem Obaid","family":"Al-Mawla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mothana Ali","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasin H.","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jgeb.2026.100788_bb0005","doi-asserted-by":"crossref","DOI":"10.1155\/av\/9970549","article-title":"Epidemiology of hepatitis B and C infections in Al-Anbar\/Iraq and correlation between viral load and liver function","volume":"2025","author":"Hamad","year":"2025","journal-title":"Adv Virol"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100788_bb0010","first-page":"51","article-title":"Hepatitis C virus infection among patients in hemodialysis unit at Baghdad teaching hospital","volume":"67","author":"Amber","year":"2021","journal-title":"Iraqi Med J"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100788_bb0015","article-title":"Sustained virological response after direct-acting antiviral therapy in hepatitis C virus-infected individuals with and without decompensated liver cirrhosis","volume":"17","author":"Radera","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.jgeb.2026.100788_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fviro.2021.742722","article-title":"Rapid diagnostics for hepatitis B and C viruses in low- and middle-income countries","volume":"1","author":"Shenge","year":"2021","journal-title":"Frontiers in Virology"},{"key":"10.1016\/j.jgeb.2026.100788_bb0045","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.4008","article-title":"HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection","volume":"5","author":"Wasitthankasem","year":"2017","journal-title":"PeerJ"},{"issue":"9","key":"10.1016\/j.jgeb.2026.100788_bb0050","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3390\/pathogens11091005","article-title":"MicroRNA-122 regulation of HCV infections: insights from studies of miR-122-independent replication","volume":"11","author":"Panigrahi","year":"2022","journal-title":"Pathogens"},{"issue":"6","key":"10.1016\/j.jgeb.2026.100788_bb0055","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s10096-025-05110-y","article-title":"A review of historical landmarks and pioneering technologies for the diagnosis of hepatitis C virus","volume":"44","author":"Sharma","year":"2025","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"10.1016\/j.jgeb.2026.100788_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/v16121863","article-title":"Hepatitis C virus core antigen: implications in diagnostic, treatment monitoring and clinical outcomes","volume":"16","author":"Le","year":"2024","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100788_bb0095","doi-asserted-by":"crossref","DOI":"10.5501\/wjv.v14.i2.101976","article-title":"Micro RNAs as a potential biomarker for predicting liver fibrosis severity in HCV-affected patients","volume":"14","author":"Kaur","year":"2025","journal-title":"World J Virol"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100788_bb0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12879-023-08016-2","article-title":"Serum MicroRNA profiles in chronic hepatitis C Egyptian patients before and after combined sofosbuvir and daclatasvir treatment","volume":"24","author":"Ezzat","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100788_bb0105","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12879-022-07292-8","article-title":"Diagnostic accuracy of circulating microRNAs for hepatitis C virus-associated hepatocellular carcinoma: a systematic review and meta-analysis","volume":"22","author":"Huang","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100788_bb0125","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1186\/s12885-023-11420-1","article-title":"Study of some potential biomarkers in Egyptian hepatitis C virus patients in relation to liver disease progression and HCC","volume":"23","author":"Baraka","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100788_bb0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12934-024-02297-1","article-title":"Glycylglycine promotes the solubility and antigenic utility of recombinant HCV structural proteins in a point-of-care immunoassay for detection of active viremia","volume":"23","author":"Shawky","year":"2024","journal-title":"Microb Cell Fact"},{"issue":"4","key":"10.1016\/j.jgeb.2026.100788_bb0070","first-page":"1","article-title":"An exhaustive update on eradication of hepatitis C virus (HCV) with the objective of eradicating chronic hepatitis by 2030","volume":"3","author":"Kaur","year":"2025","journal-title":"J Infect Dis Treat"},{"issue":"9","key":"10.1016\/j.jgeb.2026.100788_bb0075","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190900","article-title":"Diagnostic value of circulating miRNA-122 for hepatitis B and\/or hepatitis C virus-associated chronic viral hepatitis","volume":"39","author":"Zhou","year":"2019","journal-title":"Biosci Rep"},{"key":"10.1016\/j.jgeb.2026.100788_bb0080","series-title":"Circulating MicroRNA-122 as a Potential Biomarker for Hepatitis C Virus Induced Hepatocellular Carcinoma","author":"Malik","year":"2022"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100788_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268526","article-title":"Circulating microRNA-122 in HCV cirrhotic patients with high frequency of genotype 3","volume":"17","author":"Ullah","year":"2022","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100788_bb0090","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000462","article-title":"Comprehensive comparative analysis of biomarkers to enhance prognostic risk-stratification in patients with hepatitis C virus cirrhosis","volume":"13","author":"Innes","year":"2022","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jgeb.2026.100788_bb0100","first-page":"9","article-title":"Evaluation of MicroRNA-122 as a biomarker for chronic hepatitis C infection and as a predictor for response to direct-acting antivirals","author":"Elabd","year":"2021","journal-title":"Hepat Med"},{"issue":"6","key":"10.1016\/j.jgeb.2026.100788_bb0025","doi-asserted-by":"crossref","DOI":"10.5339\/jemtac.2022.aimco.7","article-title":"Impact of COVID-19 on the digestive system: a descriptive cross-sectional study","volume":"2022","author":"Wahab","year":"2022","journal-title":"J Emerg Med Trauma Acute Care"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100788_bb0030","doi-asserted-by":"crossref","DOI":"10.5339\/jemtac.2021.16","article-title":"The outcome of telemedicine services for COVID-19 patients in Al-Anbar province","volume":"2021","author":"Ali Jasim","year":"2021","journal-title":"J Emerg Med Trauma Acute Care"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100788_bb0035","doi-asserted-by":"crossref","DOI":"10.5339\/jemtac.2021.8","article-title":"Socio-clinical characteristics of COVID-19 disease in Anbar governorate, Iraq","volume":"2021","author":"Ghazzay","year":"2021","journal-title":"J Emerg Med Trauma Acute Care"},{"issue":"6","key":"10.1016\/j.jgeb.2026.100788_bb0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5339\/jemtac.2022.aimco.11","article-title":"Risk factors for hepatic manifestations in COVID-19 patients with digestive symptoms","volume":"2022","author":"Wahab","year":"2022","journal-title":"J Emerg Med Trauma Acute Care"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100788_bb0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.33091\/amj.2020.170948","article-title":"Origin, causative and new approach of vaccine design of COVID-19","volume":"16","author":"Khalil","year":"2020","journal-title":"Al-Anbar Medical Journal"},{"key":"10.1016\/j.jgeb.2026.100788_bb0120","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.11895","article-title":"Hepatitis C core antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysis","volume":"9","author":"Sadeghimehr","year":"2021","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100788_bb0040","article-title":"Is the hepatitis G virus a hidden menace to liver health in specific populations?","volume":"20","author":"Hussein","year":"2024","journal-title":"Anbar Med J"}],"container-title":["Journal of Genetic Engineering and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26001320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26001320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:50:43Z","timestamp":1789559443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687157X26001320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1687157X26001320"],"URL":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100788","relation":{},"ISSN":["1687-157X"],"issn-type":[{"value":"1687-157X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of serum MicroRNAs and HCV Core antigen as predictive and diagnostic biomarkers for chronic hepatitis C management in Iraqi patients: comparison with PCR-based detection","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetic Engineering and Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Academy of Scientific Research and Technology.","name":"copyright","label":"Copyright"}],"article-number":"100788"}}